nodes	percent_of_prediction	percent_of_DWPC	metapath
Norfloxacin—TOP2A—Etoposide—brain cancer	0.251	0.374	CbGbCtD
Norfloxacin—CYP1A2—Carmustine—brain cancer	0.129	0.193	CbGbCtD
Norfloxacin—CYP3A4—Temozolomide—brain cancer	0.0978	0.146	CbGbCtD
Norfloxacin—CYP3A4—Lomustine—brain cancer	0.0831	0.124	CbGbCtD
Norfloxacin—CYP3A5—Etoposide—brain cancer	0.0515	0.0768	CbGbCtD
Norfloxacin—CYP1A2—Etoposide—brain cancer	0.0383	0.0572	CbGbCtD
Norfloxacin—CYP3A4—Etoposide—brain cancer	0.0201	0.0299	CbGbCtD
Norfloxacin—TOP2A—Gastric Cancer Network 2—S100A6—brain cancer	0.00501	0.0591	CbGpPWpGaD
Norfloxacin—CYP2A6—CYP2E1 reactions—CYP2C9—brain cancer	0.00364	0.043	CbGpPWpGaD
Norfloxacin—CYP1A1—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.0035	0.0413	CbGpPWpGaD
Norfloxacin—CYP1A1—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00319	0.0376	CbGpPWpGaD
Norfloxacin—TOP2A—Podofilox—Etoposide—brain cancer	0.00251	0.5	CbGdCrCtD
Norfloxacin—TOP2A—Teniposide—Etoposide—brain cancer	0.00251	0.5	CbGdCrCtD
Norfloxacin—CYP3A7—Xenobiotics—CYP2C9—brain cancer	0.00246	0.0291	CbGpPWpGaD
Norfloxacin—CYP2A6—Xenobiotics—CYP2C9—brain cancer	0.00226	0.0267	CbGpPWpGaD
Norfloxacin—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP2C9—brain cancer	0.00223	0.0264	CbGpPWpGaD
Norfloxacin—CYP2A6—Tamoxifen metabolism—CYP2C9—brain cancer	0.00217	0.0256	CbGpPWpGaD
Norfloxacin—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP2C9—brain cancer	0.00203	0.024	CbGpPWpGaD
Norfloxacin—CYP3A5—Xenobiotics—CYP2C9—brain cancer	0.00178	0.021	CbGpPWpGaD
Norfloxacin—CYP3A5—Tamoxifen metabolism—CYP2C9—brain cancer	0.00171	0.0202	CbGpPWpGaD
Norfloxacin—CYP1A1—Xenobiotics—CYP2C9—brain cancer	0.00168	0.0199	CbGpPWpGaD
Norfloxacin—CYP1A1—Tamoxifen metabolism—CYP2C9—brain cancer	0.00162	0.0191	CbGpPWpGaD
Norfloxacin—CYP2A6—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00155	0.0183	CbGpPWpGaD
Norfloxacin—Dermatitis bullous—Hydroxyurea—brain cancer	0.00134	0.00559	CcSEcCtD
Norfloxacin—Photosensitivity reaction—Procarbazine—brain cancer	0.0013	0.00545	CcSEcCtD
Norfloxacin—Drowsiness—Procarbazine—brain cancer	0.00127	0.00532	CcSEcCtD
Norfloxacin—TOP2A—G0 and Early G1—CCNE1—brain cancer	0.00126	0.0148	CbGpPWpGaD
Norfloxacin—Thrombocytopenia—Lomustine—brain cancer	0.00125	0.00523	CcSEcCtD
Norfloxacin—Neuropathy peripheral—Procarbazine—brain cancer	0.00125	0.00521	CcSEcCtD
Norfloxacin—Jaundice—Procarbazine—brain cancer	0.00124	0.00519	CcSEcCtD
Norfloxacin—Stomatitis—Procarbazine—brain cancer	0.00124	0.00519	CcSEcCtD
Norfloxacin—CYP3A5—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.00122	0.0144	CbGpPWpGaD
Norfloxacin—Anorexia—Lomustine—brain cancer	0.00122	0.00509	CcSEcCtD
Norfloxacin—Haematuria—Procarbazine—brain cancer	0.00121	0.00507	CcSEcCtD
Norfloxacin—Blood creatinine increased—Hydroxyurea—brain cancer	0.0012	0.005	CcSEcCtD
Norfloxacin—Swelling—Carmustine—brain cancer	0.00117	0.0049	CcSEcCtD
Norfloxacin—Body temperature increased—Carboplatin—brain cancer	0.00116	0.00483	CcSEcCtD
Norfloxacin—Blood alkaline phosphatase increased—Temozolomide—brain cancer	0.00115	0.0048	CcSEcCtD
Norfloxacin—Eye pain—Carmustine—brain cancer	0.00115	0.00478	CcSEcCtD
Norfloxacin—Hallucination—Procarbazine—brain cancer	0.00114	0.00475	CcSEcCtD
Norfloxacin—Deafness—Temozolomide—brain cancer	0.00112	0.00467	CcSEcCtD
Norfloxacin—TOP2A—G0 and Early G1—PCNA—brain cancer	0.00111	0.0131	CbGpPWpGaD
Norfloxacin—Decreased appetite—Lomustine—brain cancer	0.00111	0.00465	CcSEcCtD
Norfloxacin—Hepatic failure—Temozolomide—brain cancer	0.00111	0.00464	CcSEcCtD
Norfloxacin—Eye pain—Temozolomide—brain cancer	0.00111	0.00462	CcSEcCtD
Norfloxacin—Phosphatase alkaline increased—Etoposide—brain cancer	0.0011	0.0046	CcSEcCtD
Norfloxacin—Pancreatitis—Hydroxyurea—brain cancer	0.00108	0.00453	CcSEcCtD
Norfloxacin—CYP1A2—Xenobiotics—CYP2C9—brain cancer	0.00107	0.0127	CbGpPWpGaD
Norfloxacin—Dermatitis exfoliative—Temozolomide—brain cancer	0.00106	0.00442	CcSEcCtD
Norfloxacin—Diplopia—Carmustine—brain cancer	0.00103	0.00432	CcSEcCtD
Norfloxacin—Neutropenia—Hydroxyurea—brain cancer	0.00103	0.00432	CcSEcCtD
Norfloxacin—CYP1A2—Tamoxifen metabolism—CYP2C9—brain cancer	0.00103	0.0122	CbGpPWpGaD
Norfloxacin—Chills—Procarbazine—brain cancer	0.00103	0.00428	CcSEcCtD
Norfloxacin—CYP3A7—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00102	0.0121	CbGpPWpGaD
Norfloxacin—Body temperature increased—Lomustine—brain cancer	0.00101	0.00422	CcSEcCtD
Norfloxacin—CYP3A7—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00101	0.0119	CbGpPWpGaD
Norfloxacin—Diplopia—Temozolomide—brain cancer	0.000999	0.00417	CcSEcCtD
Norfloxacin—Mouth ulceration—Etoposide—brain cancer	0.000996	0.00416	CcSEcCtD
Norfloxacin—Drowsiness—Hydroxyurea—brain cancer	0.000986	0.00412	CcSEcCtD
Norfloxacin—Tension—Procarbazine—brain cancer	0.000977	0.00408	CcSEcCtD
Norfloxacin—Ataxia—Carmustine—brain cancer	0.000972	0.00406	CcSEcCtD
Norfloxacin—Nervousness—Procarbazine—brain cancer	0.000967	0.00404	CcSEcCtD
Norfloxacin—Neuropathy peripheral—Hydroxyurea—brain cancer	0.000966	0.00404	CcSEcCtD
Norfloxacin—Stomatitis—Hydroxyurea—brain cancer	0.000961	0.00401	CcSEcCtD
Norfloxacin—Liver function test abnormal—Carmustine—brain cancer	0.000955	0.00399	CcSEcCtD
Norfloxacin—Ataxia—Temozolomide—brain cancer	0.00094	0.00392	CcSEcCtD
Norfloxacin—CYP2A6—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000938	0.0111	CbGpPWpGaD
Norfloxacin—Tremor—Procarbazine—brain cancer	0.000933	0.00389	CcSEcCtD
Norfloxacin—CYP2A6—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000926	0.0109	CbGpPWpGaD
Norfloxacin—Blood alkaline phosphatase increased—Etoposide—brain cancer	0.000919	0.00384	CcSEcCtD
Norfloxacin—Swelling—Etoposide—brain cancer	0.000906	0.00379	CcSEcCtD
Norfloxacin—Toxic epidermal necrolysis—Temozolomide—brain cancer	0.0009	0.00376	CcSEcCtD
Norfloxacin—Aspartate aminotransferase increased—Temozolomide—brain cancer	0.0009	0.00376	CcSEcCtD
Norfloxacin—Dysphagia—Carmustine—brain cancer	0.000894	0.00373	CcSEcCtD
Norfloxacin—Leukopenia—Procarbazine—brain cancer	0.000891	0.00372	CcSEcCtD
Norfloxacin—Hallucination—Hydroxyurea—brain cancer	0.000881	0.00368	CcSEcCtD
Norfloxacin—Dysphagia—Temozolomide—brain cancer	0.000864	0.00361	CcSEcCtD
Norfloxacin—Convulsion—Procarbazine—brain cancer	0.000862	0.0036	CcSEcCtD
Norfloxacin—Myalgia—Procarbazine—brain cancer	0.000847	0.00354	CcSEcCtD
Norfloxacin—Arthralgia—Procarbazine—brain cancer	0.000847	0.00354	CcSEcCtD
Norfloxacin—Anxiety—Procarbazine—brain cancer	0.000845	0.00353	CcSEcCtD
Norfloxacin—Neutropenia—Carmustine—brain cancer	0.000836	0.00349	CcSEcCtD
Norfloxacin—CYP3A7—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00083	0.00979	CbGpPWpGaD
Norfloxacin—Dry mouth—Procarbazine—brain cancer	0.000829	0.00346	CcSEcCtD
Norfloxacin—CYP3A4—Xenobiotics—CYP2C9—brain cancer	0.000828	0.00978	CbGpPWpGaD
Norfloxacin—Anaphylactoid reaction—Etoposide—brain cancer	0.000826	0.00345	CcSEcCtD
Norfloxacin—Confusional state—Procarbazine—brain cancer	0.000819	0.00342	CcSEcCtD
Norfloxacin—Vomiting—Lomustine—brain cancer	0.000814	0.0034	CcSEcCtD
Norfloxacin—Oedema—Procarbazine—brain cancer	0.000812	0.00339	CcSEcCtD
Norfloxacin—CYP1A1—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000809	0.00954	CbGpPWpGaD
Norfloxacin—Neutropenia—Temozolomide—brain cancer	0.000808	0.00337	CcSEcCtD
Norfloxacin—TOP2A—Gastric Cancer Network 1—APC—brain cancer	0.000804	0.00949	CbGpPWpGaD
Norfloxacin—CYP3A4—Tamoxifen metabolism—CYP2C9—brain cancer	0.000797	0.0094	CbGpPWpGaD
Norfloxacin—Thrombocytopenia—Procarbazine—brain cancer	0.000795	0.00332	CcSEcCtD
Norfloxacin—Chills—Hydroxyurea—brain cancer	0.000794	0.00332	CcSEcCtD
Norfloxacin—Photosensitivity reaction—Temozolomide—brain cancer	0.000788	0.00329	CcSEcCtD
Norfloxacin—Hyperhidrosis—Procarbazine—brain cancer	0.000785	0.00328	CcSEcCtD
Norfloxacin—Renal failure—Carmustine—brain cancer	0.000783	0.00327	CcSEcCtD
Norfloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—BRCA2—brain cancer	0.000783	0.00924	CbGpPWpGaD
Norfloxacin—Neuropathy peripheral—Carmustine—brain cancer	0.000781	0.00326	CcSEcCtD
Norfloxacin—Stomatitis—Carmustine—brain cancer	0.000777	0.00324	CcSEcCtD
Norfloxacin—Anorexia—Procarbazine—brain cancer	0.000774	0.00323	CcSEcCtD
Norfloxacin—Erythema—Hydroxyurea—brain cancer	0.00077	0.00322	CcSEcCtD
Norfloxacin—Stevens-Johnson syndrome—Temozolomide—brain cancer	0.000764	0.00319	CcSEcCtD
Norfloxacin—CYP2A6—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.00076	0.00898	CbGpPWpGaD
Norfloxacin—Nausea—Lomustine—brain cancer	0.00076	0.00317	CcSEcCtD
Norfloxacin—Neuropathy peripheral—Temozolomide—brain cancer	0.000755	0.00315	CcSEcCtD
Norfloxacin—Stomatitis—Temozolomide—brain cancer	0.000751	0.00314	CcSEcCtD
Norfloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—HES1—brain cancer	0.00074	0.00874	CbGpPWpGaD
Norfloxacin—Musculoskeletal discomfort—Procarbazine—brain cancer	0.00074	0.00309	CcSEcCtD
Norfloxacin—CYP3A5—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.00074	0.00873	CbGpPWpGaD
Norfloxacin—Insomnia—Procarbazine—brain cancer	0.000735	0.00307	CcSEcCtD
Norfloxacin—CYP3A5—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00073	0.00862	CbGpPWpGaD
Norfloxacin—Paraesthesia—Procarbazine—brain cancer	0.000729	0.00305	CcSEcCtD
Norfloxacin—TOP2A—Circadian rythm related genes—NTRK3—brain cancer	0.000723	0.00853	CbGpPWpGaD
Norfloxacin—Somnolence—Procarbazine—brain cancer	0.000722	0.00302	CcSEcCtD
Norfloxacin—Cramp muscle—Etoposide—brain cancer	0.00072	0.00301	CcSEcCtD
Norfloxacin—Toxic epidermal necrolysis—Etoposide—brain cancer	0.00072	0.00301	CcSEcCtD
Norfloxacin—Hallucination—Carmustine—brain cancer	0.000712	0.00297	CcSEcCtD
Norfloxacin—Hypoaesthesia—Carmustine—brain cancer	0.000712	0.00297	CcSEcCtD
Norfloxacin—Decreased appetite—Procarbazine—brain cancer	0.000706	0.00295	CcSEcCtD
Norfloxacin—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000702	0.00829	CbGpPWpGaD
Norfloxacin—Fatigue—Procarbazine—brain cancer	0.0007	0.00293	CcSEcCtD
Norfloxacin—CYP1A1—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000699	0.00825	CbGpPWpGaD
Norfloxacin—Constipation—Procarbazine—brain cancer	0.000695	0.0029	CcSEcCtD
Norfloxacin—Hepatitis—Temozolomide—brain cancer	0.000691	0.00289	CcSEcCtD
Norfloxacin—Dysphagia—Etoposide—brain cancer	0.000691	0.00289	CcSEcCtD
Norfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—SKP2—brain cancer	0.00069	0.00814	CbGpPWpGaD
Norfloxacin—CYP1A1—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00069	0.00814	CbGpPWpGaD
Norfloxacin—Leukopenia—Hydroxyurea—brain cancer	0.00069	0.00288	CcSEcCtD
Norfloxacin—Visual impairment—Carmustine—brain cancer	0.000689	0.00288	CcSEcCtD
Norfloxacin—Hallucination—Temozolomide—brain cancer	0.000688	0.00287	CcSEcCtD
Norfloxacin—Hypoaesthesia—Temozolomide—brain cancer	0.000688	0.00287	CcSEcCtD
Norfloxacin—Feeling abnormal—Procarbazine—brain cancer	0.000669	0.0028	CcSEcCtD
Norfloxacin—Convulsion—Hydroxyurea—brain cancer	0.000667	0.00279	CcSEcCtD
Norfloxacin—Visual impairment—Temozolomide—brain cancer	0.000666	0.00278	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Procarbazine—brain cancer	0.000664	0.00277	CcSEcCtD
Norfloxacin—Erythema multiforme—Temozolomide—brain cancer	0.000654	0.00273	CcSEcCtD
Norfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—DNMT1—brain cancer	0.000649	0.00766	CbGpPWpGaD
Norfloxacin—Neutropenia—Etoposide—brain cancer	0.000646	0.0027	CcSEcCtD
Norfloxacin—Urticaria—Procarbazine—brain cancer	0.000645	0.0027	CcSEcCtD
Norfloxacin—Tinnitus—Temozolomide—brain cancer	0.000645	0.00269	CcSEcCtD
Norfloxacin—Body temperature increased—Procarbazine—brain cancer	0.000642	0.00268	CcSEcCtD
Norfloxacin—Abdominal pain—Procarbazine—brain cancer	0.000642	0.00268	CcSEcCtD
Norfloxacin—Oedema—Hydroxyurea—brain cancer	0.000629	0.00263	CcSEcCtD
Norfloxacin—CYP3A5—Irinotecan Pathway—APC—brain cancer	0.000628	0.00742	CbGpPWpGaD
Norfloxacin—Erythema—Carmustine—brain cancer	0.000623	0.0026	CcSEcCtD
Norfloxacin—Chills—Temozolomide—brain cancer	0.00062	0.00259	CcSEcCtD
Norfloxacin—Thrombocytopenia—Hydroxyurea—brain cancer	0.000616	0.00257	CcSEcCtD
Norfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDK6—brain cancer	0.000615	0.00726	CbGpPWpGaD
Norfloxacin—Stevens-Johnson syndrome—Etoposide—brain cancer	0.000611	0.00255	CcSEcCtD
Norfloxacin—Acute coronary syndrome—Etoposide—brain cancer	0.000608	0.00254	CcSEcCtD
Norfloxacin—Renal failure—Etoposide—brain cancer	0.000606	0.00253	CcSEcCtD
Norfloxacin—Myocardial infarction—Etoposide—brain cancer	0.000604	0.00252	CcSEcCtD
Norfloxacin—Neuropathy peripheral—Etoposide—brain cancer	0.000604	0.00252	CcSEcCtD
Norfloxacin—Back pain—Carmustine—brain cancer	0.000602	0.00252	CcSEcCtD
Norfloxacin—Erythema—Temozolomide—brain cancer	0.000602	0.00251	CcSEcCtD
Norfloxacin—Jaundice—Etoposide—brain cancer	0.000601	0.00251	CcSEcCtD
Norfloxacin—Stomatitis—Etoposide—brain cancer	0.000601	0.00251	CcSEcCtD
Norfloxacin—CYP3A5—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.0006	0.00708	CbGpPWpGaD
Norfloxacin—Anorexia—Hydroxyurea—brain cancer	0.000599	0.0025	CcSEcCtD
Norfloxacin—Hypersensitivity—Procarbazine—brain cancer	0.000599	0.0025	CcSEcCtD
Norfloxacin—Dysgeusia—Temozolomide—brain cancer	0.000589	0.00246	CcSEcCtD
Norfloxacin—Vision blurred—Carmustine—brain cancer	0.000587	0.00245	CcSEcCtD
Norfloxacin—Tremor—Carmustine—brain cancer	0.000583	0.00244	CcSEcCtD
Norfloxacin—Asthenia—Procarbazine—brain cancer	0.000583	0.00243	CcSEcCtD
Norfloxacin—Back pain—Temozolomide—brain cancer	0.000582	0.00243	CcSEcCtD
Norfloxacin—Agranulocytosis—Etoposide—brain cancer	0.000575	0.0024	CcSEcCtD
Norfloxacin—Pruritus—Procarbazine—brain cancer	0.000575	0.0024	CcSEcCtD
Norfloxacin—Agitation—Carmustine—brain cancer	0.000572	0.00239	CcSEcCtD
Norfloxacin—CYP3A4—Constitutive Androstane Receptor Pathway—CYP2C9—brain cancer	0.000569	0.00671	CbGpPWpGaD
Norfloxacin—Vision blurred—Temozolomide—brain cancer	0.000567	0.00237	CcSEcCtD
Norfloxacin—CYP1A1—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000567	0.00669	CbGpPWpGaD
Norfloxacin—Tremor—Temozolomide—brain cancer	0.000564	0.00235	CcSEcCtD
Norfloxacin—Dyspnoea—Hydroxyurea—brain cancer	0.000561	0.00234	CcSEcCtD
Norfloxacin—Somnolence—Hydroxyurea—brain cancer	0.000559	0.00233	CcSEcCtD
Norfloxacin—Leukopenia—Carmustine—brain cancer	0.000557	0.00233	CcSEcCtD
Norfloxacin—Diarrhoea—Procarbazine—brain cancer	0.000556	0.00232	CcSEcCtD
Norfloxacin—Dyspepsia—Hydroxyurea—brain cancer	0.000553	0.00231	CcSEcCtD
Norfloxacin—Agitation—Temozolomide—brain cancer	0.000553	0.00231	CcSEcCtD
Norfloxacin—Hypoaesthesia—Etoposide—brain cancer	0.00055	0.0023	CcSEcCtD
Norfloxacin—Angioedema—Temozolomide—brain cancer	0.00055	0.0023	CcSEcCtD
Norfloxacin—Decreased appetite—Hydroxyurea—brain cancer	0.000547	0.00228	CcSEcCtD
Norfloxacin—Fatigue—Hydroxyurea—brain cancer	0.000542	0.00226	CcSEcCtD
Norfloxacin—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP2C9—brain cancer	0.000542	0.00639	CbGpPWpGaD
Norfloxacin—Vertigo—Temozolomide—brain cancer	0.000541	0.00226	CcSEcCtD
Norfloxacin—Convulsion—Carmustine—brain cancer	0.00054	0.00225	CcSEcCtD
Norfloxacin—Leukopenia—Temozolomide—brain cancer	0.000539	0.00225	CcSEcCtD
Norfloxacin—Constipation—Hydroxyurea—brain cancer	0.000538	0.00225	CcSEcCtD
Norfloxacin—Dizziness—Procarbazine—brain cancer	0.000537	0.00224	CcSEcCtD
Norfloxacin—Palpitations—Temozolomide—brain cancer	0.000532	0.00222	CcSEcCtD
Norfloxacin—Chest pain—Carmustine—brain cancer	0.00053	0.00221	CcSEcCtD
Norfloxacin—Myalgia—Carmustine—brain cancer	0.00053	0.00221	CcSEcCtD
Norfloxacin—Anxiety—Carmustine—brain cancer	0.000528	0.00221	CcSEcCtD
Norfloxacin—Erythema multiforme—Etoposide—brain cancer	0.000523	0.00218	CcSEcCtD
Norfloxacin—Convulsion—Temozolomide—brain cancer	0.000521	0.00218	CcSEcCtD
Norfloxacin—Feeling abnormal—Hydroxyurea—brain cancer	0.000518	0.00216	CcSEcCtD
Norfloxacin—TOP2A—Gastric Cancer Network 2—CTNNB1—brain cancer	0.000518	0.00611	CbGpPWpGaD
Norfloxacin—Vomiting—Procarbazine—brain cancer	0.000517	0.00216	CcSEcCtD
Norfloxacin—CYP1A2—Arachidonic acid metabolism—CYP2C9—brain cancer	0.000516	0.00609	CbGpPWpGaD
Norfloxacin—Confusional state—Carmustine—brain cancer	0.000512	0.00214	CcSEcCtD
Norfloxacin—Myalgia—Temozolomide—brain cancer	0.000512	0.00214	CcSEcCtD
Norfloxacin—Arthralgia—Temozolomide—brain cancer	0.000512	0.00214	CcSEcCtD
Norfloxacin—Rash—Procarbazine—brain cancer	0.000512	0.00214	CcSEcCtD
Norfloxacin—Dermatitis—Procarbazine—brain cancer	0.000512	0.00214	CcSEcCtD
Norfloxacin—Anxiety—Temozolomide—brain cancer	0.000511	0.00213	CcSEcCtD
Norfloxacin—Headache—Procarbazine—brain cancer	0.000509	0.00213	CcSEcCtD
Norfloxacin—Oedema—Carmustine—brain cancer	0.000508	0.00212	CcSEcCtD
Norfloxacin—Dry mouth—Temozolomide—brain cancer	0.000501	0.00209	CcSEcCtD
Norfloxacin—Thrombocytopenia—Carmustine—brain cancer	0.000498	0.00208	CcSEcCtD
Norfloxacin—Body temperature increased—Hydroxyurea—brain cancer	0.000497	0.00208	CcSEcCtD
Norfloxacin—Chills—Etoposide—brain cancer	0.000496	0.00207	CcSEcCtD
Norfloxacin—Confusional state—Temozolomide—brain cancer	0.000495	0.00207	CcSEcCtD
Norfloxacin—Oedema—Temozolomide—brain cancer	0.000491	0.00205	CcSEcCtD
Norfloxacin—Anaphylactic shock—Temozolomide—brain cancer	0.000491	0.00205	CcSEcCtD
Norfloxacin—TOP2A—Mitotic G1-G1/S phases—SKP2—brain cancer	0.000486	0.00573	CbGpPWpGaD
Norfloxacin—Anorexia—Carmustine—brain cancer	0.000484	0.00202	CcSEcCtD
Norfloxacin—Nausea—Procarbazine—brain cancer	0.000483	0.00202	CcSEcCtD
Norfloxacin—Thrombocytopenia—Temozolomide—brain cancer	0.000481	0.00201	CcSEcCtD
Norfloxacin—Hyperhidrosis—Temozolomide—brain cancer	0.000475	0.00198	CcSEcCtD
Norfloxacin—Dysgeusia—Etoposide—brain cancer	0.000472	0.00197	CcSEcCtD
Norfloxacin—Anorexia—Temozolomide—brain cancer	0.000468	0.00196	CcSEcCtD
Norfloxacin—Back pain—Etoposide—brain cancer	0.000466	0.00195	CcSEcCtD
Norfloxacin—Hypersensitivity—Hydroxyurea—brain cancer	0.000463	0.00193	CcSEcCtD
Norfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCNE1—brain cancer	0.000463	0.00547	CbGpPWpGaD
Norfloxacin—Musculoskeletal discomfort—Carmustine—brain cancer	0.000463	0.00193	CcSEcCtD
Norfloxacin—Muscle spasms—Etoposide—brain cancer	0.000463	0.00193	CcSEcCtD
Norfloxacin—Insomnia—Carmustine—brain cancer	0.00046	0.00192	CcSEcCtD
Norfloxacin—Paraesthesia—Carmustine—brain cancer	0.000456	0.00191	CcSEcCtD
Norfloxacin—Dyspnoea—Carmustine—brain cancer	0.000453	0.00189	CcSEcCtD
Norfloxacin—Somnolence—Carmustine—brain cancer	0.000452	0.00189	CcSEcCtD
Norfloxacin—Asthenia—Hydroxyurea—brain cancer	0.000451	0.00188	CcSEcCtD
Norfloxacin—Musculoskeletal discomfort—Temozolomide—brain cancer	0.000448	0.00187	CcSEcCtD
Norfloxacin—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000446	0.00526	CbGpPWpGaD
Norfloxacin—Insomnia—Temozolomide—brain cancer	0.000444	0.00186	CcSEcCtD
Norfloxacin—TOP2A—Validated transcriptional targets of deltaNp63 isoforms—CDKN2A—brain cancer	0.000444	0.00524	CbGpPWpGaD
Norfloxacin—Decreased appetite—Carmustine—brain cancer	0.000442	0.00185	CcSEcCtD
Norfloxacin—Paraesthesia—Temozolomide—brain cancer	0.000441	0.00184	CcSEcCtD
Norfloxacin—CYP3A7—Biological oxidations—CYP2C9—brain cancer	0.000441	0.0052	CbGpPWpGaD
Norfloxacin—CYP1A2—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.00044	0.00519	CbGpPWpGaD
Norfloxacin—Dyspnoea—Temozolomide—brain cancer	0.000438	0.00183	CcSEcCtD
Norfloxacin—Somnolence—Temozolomide—brain cancer	0.000437	0.00182	CcSEcCtD
Norfloxacin—CYP1A1—Oxidative Stress—SOD2—brain cancer	0.000436	0.00515	CbGpPWpGaD
Norfloxacin—CYP3A7—Metapathway biotransformation—CYP2C9—brain cancer	0.000435	0.00513	CbGpPWpGaD
Norfloxacin—Constipation—Carmustine—brain cancer	0.000435	0.00182	CcSEcCtD
Norfloxacin—TOP2A—Mitotic G1-G1/S phases—CDK6—brain cancer	0.000433	0.00511	CbGpPWpGaD
Norfloxacin—Vertigo—Etoposide—brain cancer	0.000433	0.00181	CcSEcCtD
Norfloxacin—Dyspepsia—Temozolomide—brain cancer	0.000432	0.00181	CcSEcCtD
Norfloxacin—Leukopenia—Etoposide—brain cancer	0.000431	0.0018	CcSEcCtD
Norfloxacin—Diarrhoea—Hydroxyurea—brain cancer	0.00043	0.0018	CcSEcCtD
Norfloxacin—CYP2A6—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—VEGFA—brain cancer	0.000428	0.00505	CbGpPWpGaD
Norfloxacin—Decreased appetite—Temozolomide—brain cancer	0.000427	0.00178	CcSEcCtD
Norfloxacin—Fatigue—Temozolomide—brain cancer	0.000423	0.00177	CcSEcCtD
Norfloxacin—Constipation—Temozolomide—brain cancer	0.00042	0.00175	CcSEcCtD
Norfloxacin—TOP2A—Gastric Cancer Network 2—MYC—brain cancer	0.000419	0.00495	CbGpPWpGaD
Norfloxacin—Feeling abnormal—Carmustine—brain cancer	0.000419	0.00175	CcSEcCtD
Norfloxacin—Convulsion—Etoposide—brain cancer	0.000417	0.00174	CcSEcCtD
Norfloxacin—Dizziness—Hydroxyurea—brain cancer	0.000416	0.00174	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Carmustine—brain cancer	0.000416	0.00174	CcSEcCtD
Norfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—PCNA—brain cancer	0.00041	0.00484	CbGpPWpGaD
Norfloxacin—TOP2A—Gastric Cancer Network 2—EGFR—brain cancer	0.00041	0.00484	CbGpPWpGaD
Norfloxacin—Chest pain—Etoposide—brain cancer	0.00041	0.00171	CcSEcCtD
Norfloxacin—Feeling abnormal—Temozolomide—brain cancer	0.000405	0.00169	CcSEcCtD
Norfloxacin—CYP2A6—Biological oxidations—CYP2C9—brain cancer	0.000404	0.00477	CbGpPWpGaD
Norfloxacin—Abdominal pain—Carmustine—brain cancer	0.000402	0.00168	CcSEcCtD
Norfloxacin—Body temperature increased—Carmustine—brain cancer	0.000402	0.00168	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Temozolomide—brain cancer	0.000402	0.00168	CcSEcCtD
Norfloxacin—Vomiting—Hydroxyurea—brain cancer	0.0004	0.00167	CcSEcCtD
Norfloxacin—Rash—Hydroxyurea—brain cancer	0.000396	0.00166	CcSEcCtD
Norfloxacin—Confusional state—Etoposide—brain cancer	0.000396	0.00166	CcSEcCtD
Norfloxacin—Dermatitis—Hydroxyurea—brain cancer	0.000396	0.00165	CcSEcCtD
Norfloxacin—Headache—Hydroxyurea—brain cancer	0.000394	0.00164	CcSEcCtD
Norfloxacin—Anaphylactic shock—Etoposide—brain cancer	0.000393	0.00164	CcSEcCtD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—PPP1R12A—brain cancer	0.000392	0.00463	CbGpPWpGaD
Norfloxacin—Urticaria—Temozolomide—brain cancer	0.00039	0.00163	CcSEcCtD
Norfloxacin—Body temperature increased—Temozolomide—brain cancer	0.000388	0.00162	CcSEcCtD
Norfloxacin—Abdominal pain—Temozolomide—brain cancer	0.000388	0.00162	CcSEcCtD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—SHH—brain cancer	0.000388	0.00458	CbGpPWpGaD
Norfloxacin—Thrombocytopenia—Etoposide—brain cancer	0.000385	0.00161	CcSEcCtD
Norfloxacin—Hyperhidrosis—Etoposide—brain cancer	0.00038	0.00159	CcSEcCtD
Norfloxacin—Anorexia—Etoposide—brain cancer	0.000375	0.00156	CcSEcCtD
Norfloxacin—Hypersensitivity—Carmustine—brain cancer	0.000374	0.00156	CcSEcCtD
Norfloxacin—Nausea—Hydroxyurea—brain cancer	0.000373	0.00156	CcSEcCtD
Norfloxacin—CYP1A1—Estrogen Receptor Pathway—STAT3—brain cancer	0.000373	0.0044	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—SMO—brain cancer	0.000368	0.00434	CbGpPWpGaD
Norfloxacin—Asthenia—Carmustine—brain cancer	0.000365	0.00152	CcSEcCtD
Norfloxacin—Hypersensitivity—Temozolomide—brain cancer	0.000362	0.00151	CcSEcCtD
Norfloxacin—CYP1A2—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000361	0.00426	CbGpPWpGaD
Norfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CDK4—brain cancer	0.000355	0.00419	CbGpPWpGaD
Norfloxacin—Paraesthesia—Etoposide—brain cancer	0.000353	0.00147	CcSEcCtD
Norfloxacin—Asthenia—Temozolomide—brain cancer	0.000352	0.00147	CcSEcCtD
Norfloxacin—TOP2A—Cell Cycle—PPP1R12A—brain cancer	0.000351	0.00414	CbGpPWpGaD
Norfloxacin—Dyspnoea—Etoposide—brain cancer	0.00035	0.00146	CcSEcCtD
Norfloxacin—Somnolence—Etoposide—brain cancer	0.000349	0.00146	CcSEcCtD
Norfloxacin—Diarrhoea—Carmustine—brain cancer	0.000348	0.00145	CcSEcCtD
Norfloxacin—Pruritus—Temozolomide—brain cancer	0.000348	0.00145	CcSEcCtD
Norfloxacin—TOP2A—Gastric Cancer Network 2—TP53—brain cancer	0.000344	0.00407	CbGpPWpGaD
Norfloxacin—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2C9—brain cancer	0.000344	0.00406	CbGpPWpGaD
Norfloxacin—Decreased appetite—Etoposide—brain cancer	0.000342	0.00143	CcSEcCtD
Norfloxacin—CYP3A4—Oxidation by Cytochrome P450—CYP2C9—brain cancer	0.000339	0.00401	CbGpPWpGaD
Norfloxacin—Fatigue—Etoposide—brain cancer	0.000339	0.00142	CcSEcCtD
Norfloxacin—Dizziness—Carmustine—brain cancer	0.000336	0.0014	CcSEcCtD
Norfloxacin—Constipation—Etoposide—brain cancer	0.000336	0.0014	CcSEcCtD
Norfloxacin—Diarrhoea—Temozolomide—brain cancer	0.000336	0.0014	CcSEcCtD
Norfloxacin—TOP2A—Mitotic G1-G1/S phases—CCNE1—brain cancer	0.000326	0.00385	CbGpPWpGaD
Norfloxacin—Dizziness—Temozolomide—brain cancer	0.000325	0.00136	CcSEcCtD
Norfloxacin—Feeling abnormal—Etoposide—brain cancer	0.000324	0.00135	CcSEcCtD
Norfloxacin—Vomiting—Carmustine—brain cancer	0.000323	0.00135	CcSEcCtD
Norfloxacin—Gastrointestinal pain—Etoposide—brain cancer	0.000321	0.00134	CcSEcCtD
Norfloxacin—Rash—Carmustine—brain cancer	0.00032	0.00134	CcSEcCtD
Norfloxacin—Dermatitis—Carmustine—brain cancer	0.00032	0.00134	CcSEcCtD
Norfloxacin—CYP3A5—Biological oxidations—CYP2C9—brain cancer	0.000319	0.00376	CbGpPWpGaD
Norfloxacin—Headache—Carmustine—brain cancer	0.000318	0.00133	CcSEcCtD
Norfloxacin—CYP3A5—Metapathway biotransformation—CYP2C9—brain cancer	0.000314	0.00371	CbGpPWpGaD
Norfloxacin—Vomiting—Temozolomide—brain cancer	0.000312	0.0013	CcSEcCtD
Norfloxacin—Urticaria—Etoposide—brain cancer	0.000312	0.0013	CcSEcCtD
Norfloxacin—Abdominal pain—Etoposide—brain cancer	0.000311	0.0013	CcSEcCtD
Norfloxacin—Body temperature increased—Etoposide—brain cancer	0.000311	0.0013	CcSEcCtD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ESR2—brain cancer	0.00031	0.00366	CbGpPWpGaD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.00031	0.00366	CbGpPWpGaD
Norfloxacin—Rash—Temozolomide—brain cancer	0.00031	0.00129	CcSEcCtD
Norfloxacin—Dermatitis—Temozolomide—brain cancer	0.000309	0.00129	CcSEcCtD
Norfloxacin—SLC22A5—Transmembrane transport of small molecules—S100A10—brain cancer	0.000308	0.00364	CbGpPWpGaD
Norfloxacin—Headache—Temozolomide—brain cancer	0.000308	0.00129	CcSEcCtD
Norfloxacin—Nausea—Carmustine—brain cancer	0.000302	0.00126	CcSEcCtD
Norfloxacin—CYP1A1—Biological oxidations—CYP2C9—brain cancer	0.000301	0.00355	CbGpPWpGaD
Norfloxacin—CYP1A1—Metapathway biotransformation—CYP2C9—brain cancer	0.000297	0.0035	CbGpPWpGaD
Norfloxacin—CYP3A4—Irinotecan Pathway—APC—brain cancer	0.000292	0.00345	CbGpPWpGaD
Norfloxacin—Nausea—Temozolomide—brain cancer	0.000292	0.00122	CcSEcCtD
Norfloxacin—Hypersensitivity—Etoposide—brain cancer	0.00029	0.00121	CcSEcCtD
Norfloxacin—TOP2A—Mitotic G1-G1/S phases—PCNA—brain cancer	0.000289	0.00341	CbGpPWpGaD
Norfloxacin—Asthenia—Etoposide—brain cancer	0.000282	0.00118	CcSEcCtD
Norfloxacin—CYP3A4—Phase 1 - Functionalization of compounds—CYP2C9—brain cancer	0.000279	0.00329	CbGpPWpGaD
Norfloxacin—Pruritus—Etoposide—brain cancer	0.000278	0.00116	CcSEcCtD
Norfloxacin—Diarrhoea—Etoposide—brain cancer	0.000269	0.00112	CcSEcCtD
Norfloxacin—Dizziness—Etoposide—brain cancer	0.00026	0.00109	CcSEcCtD
Norfloxacin—CYP3A4—Farnesoid X Receptor  Pathway—IRS2—brain cancer	0.000259	0.00306	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—BRCA2—brain cancer	0.000255	0.00301	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—SIRT1—brain cancer	0.00025	0.00295	CbGpPWpGaD
Norfloxacin—Vomiting—Etoposide—brain cancer	0.00025	0.00104	CcSEcCtD
Norfloxacin—TOP2A—Mitotic G1-G1/S phases—CDK4—brain cancer	0.00025	0.00295	CbGpPWpGaD
Norfloxacin—Rash—Etoposide—brain cancer	0.000248	0.00103	CcSEcCtD
Norfloxacin—Dermatitis—Etoposide—brain cancer	0.000248	0.00103	CcSEcCtD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCNE1—brain cancer	0.000247	0.00291	CbGpPWpGaD
Norfloxacin—Headache—Etoposide—brain cancer	0.000246	0.00103	CcSEcCtD
Norfloxacin—TOP2A—Circadian rythm related genes—SIRT1—brain cancer	0.00024	0.00283	CbGpPWpGaD
Norfloxacin—CYP1A2—Estrogen Receptor Pathway—STAT3—brain cancer	0.000238	0.00281	CbGpPWpGaD
Norfloxacin—Nausea—Etoposide—brain cancer	0.000233	0.000975	CcSEcCtD
Norfloxacin—SLC22A6—Transmembrane transport of small molecules—S100A10—brain cancer	0.000233	0.00275	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PDGFRA—brain cancer	0.00023	0.00271	CbGpPWpGaD
Norfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—CCND1—brain cancer	0.000229	0.0027	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—PCNA—brain cancer	0.000219	0.00258	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—HES1—brain cancer	0.000198	0.00234	CbGpPWpGaD
Norfloxacin—CYP1A2—Biological oxidations—CYP2C9—brain cancer	0.000192	0.00227	CbGpPWpGaD
Norfloxacin—TOP2A—Mitotic G1-G1/S phases—CDKN2A—brain cancer	0.000191	0.00225	CbGpPWpGaD
Norfloxacin—CYP1A2—Metapathway biotransformation—CYP2C9—brain cancer	0.000189	0.00223	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CDK4—brain cancer	0.000189	0.00223	CbGpPWpGaD
Norfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—MYC—brain cancer	0.000184	0.00217	CbGpPWpGaD
Norfloxacin—TOP2A—Circadian rythm related genes—CDK4—brain cancer	0.000182	0.00214	CbGpPWpGaD
Norfloxacin—CYP2A6—Fluoropyrimidine Activity—TP53—brain cancer	0.000181	0.00214	CbGpPWpGaD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor—RELA—brain cancer	0.000179	0.00211	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—SKP2—brain cancer	0.000178	0.0021	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—APC—brain cancer	0.000178	0.0021	CbGpPWpGaD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	0.000161	0.0019	CbGpPWpGaD
Norfloxacin—TOP2A—Mitotic G1-G1/S phases—CCND1—brain cancer	0.000161	0.0019	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—SKP2—brain cancer	0.000159	0.00188	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—CDK6—brain cancer	0.000159	0.00187	CbGpPWpGaD
Norfloxacin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—brain cancer	0.000151	0.00178	CbGpPWpGaD
Norfloxacin—CYP3A4—Biological oxidations—CYP2C9—brain cancer	0.000148	0.00175	CbGpPWpGaD
Norfloxacin—CYP3A4—Metapathway biotransformation—CYP2C9—brain cancer	0.000146	0.00172	CbGpPWpGaD
Norfloxacin—SLC22A5—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000142	0.00168	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—CDK6—brain cancer	0.000142	0.00168	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—brain cancer	0.000138	0.00163	CbGpPWpGaD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	0.000137	0.00162	CbGpPWpGaD
Norfloxacin—TOP2A—Mitotic G1-G1/S phases—MYC—brain cancer	0.000129	0.00153	CbGpPWpGaD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor—MYC—brain cancer	0.000126	0.00149	CbGpPWpGaD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor—EGFR—brain cancer	0.000123	0.00146	CbGpPWpGaD
Norfloxacin—CYP1A1—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	0.000123	0.00146	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CCND1—brain cancer	0.000122	0.00144	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—CTNNB1—brain cancer	0.000121	0.00143	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—CCNE1—brain cancer	0.00012	0.00141	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	0.000116	0.00136	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor—RELA—brain cancer	0.000114	0.00135	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—BRCA2—brain cancer	0.00011	0.0013	CbGpPWpGaD
Norfloxacin—SLC22A6—Transmembrane transport of small molecules—TRPC6—brain cancer	0.000107	0.00127	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—CCNE1—brain cancer	0.000107	0.00126	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—VEGFA—brain cancer	0.000106	0.00126	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—PCNA—brain cancer	0.000106	0.00125	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—IL2—brain cancer	0.000103	0.00121	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—MYC—brain cancer	9.79e-05	0.00116	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—brain cancer	9.58e-05	0.00113	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—PCNA—brain cancer	9.47e-05	0.00112	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—CDK4—brain cancer	9.15e-05	0.00108	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—brain cancer	8.74e-05	0.00103	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—IDH1—brain cancer	8.45e-05	0.000997	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—CDK4—brain cancer	8.19e-05	0.000966	CbGpPWpGaD
Norfloxacin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—brain cancer	8.04e-05	0.000949	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor—MYC—brain cancer	8.04e-05	0.000949	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—brain cancer	7.87e-05	0.000928	CbGpPWpGaD
Norfloxacin—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—brain cancer	7.87e-05	0.000928	CbGpPWpGaD
Norfloxacin—TOP2A—Circadian rythm related genes—TP53—brain cancer	7.72e-05	0.000911	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—CYP2C9—brain cancer	7.54e-05	0.00089	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—CYP2C9—brain cancer	7.37e-05	0.00087	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—CDKN2A—brain cancer	7e-05	0.000826	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—CYP2C9—brain cancer	6.91e-05	0.000815	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—BSG—brain cancer	6.41e-05	0.000756	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—CDKN2A—brain cancer	6.26e-05	0.000738	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—CCND1—brain cancer	5.91e-05	0.000698	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—BSG—brain cancer	5.87e-05	0.000693	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—IDH1—brain cancer	5.51e-05	0.00065	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—CYP2C9—brain cancer	5.45e-05	0.000643	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—IDH1—brain cancer	5.39e-05	0.000636	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—CCND1—brain cancer	5.29e-05	0.000624	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—CYP2C9—brain cancer	5.15e-05	0.000608	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—IDH1—brain cancer	5.05e-05	0.000596	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle, Mitotic—MYC—brain cancer	4.74e-05	0.00056	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—BSG—brain cancer	4.63e-05	0.000547	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—BSG—brain cancer	4.38e-05	0.000517	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—ENO2—brain cancer	4.36e-05	0.000514	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—MYC—brain cancer	4.24e-05	0.0005	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—ENO2—brain cancer	3.99e-05	0.000471	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—IDH1—brain cancer	3.98e-05	0.00047	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—IDH1—brain cancer	3.76e-05	0.000444	CbGpPWpGaD
Norfloxacin—TOP2A—Cell Cycle—TP53—brain cancer	3.48e-05	0.000411	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—CYP2C9—brain cancer	3.28e-05	0.000387	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—ENO2—brain cancer	3.15e-05	0.000372	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	3.06e-05	0.000362	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—ENO2—brain cancer	2.97e-05	0.000351	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—BSG—brain cancer	2.79e-05	0.000329	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—CYP2C9—brain cancer	2.53e-05	0.000299	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—IDH1—brain cancer	2.4e-05	0.000283	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—BSG—brain cancer	2.15e-05	0.000254	CbGpPWpGaD
Norfloxacin—CYP3A7—Metabolism—PIK3CG—brain cancer	2e-05	0.000236	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—brain cancer	1.95e-05	0.000231	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—ENO2—brain cancer	1.9e-05	0.000224	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—IDH1—brain cancer	1.85e-05	0.000219	CbGpPWpGaD
Norfloxacin—CYP2A6—Metabolism—PIK3CG—brain cancer	1.83e-05	0.000216	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—ENO2—brain cancer	1.46e-05	0.000173	CbGpPWpGaD
Norfloxacin—CYP3A5—Metabolism—PIK3CG—brain cancer	1.44e-05	0.00017	CbGpPWpGaD
Norfloxacin—CYP1A1—Metabolism—PIK3CG—brain cancer	1.36e-05	0.000161	CbGpPWpGaD
Norfloxacin—CYP1A2—Metabolism—PIK3CG—brain cancer	8.7e-06	0.000103	CbGpPWpGaD
Norfloxacin—CYP3A4—Metabolism—PIK3CG—brain cancer	6.72e-06	7.93e-05	CbGpPWpGaD
